CN101991841A - Medical composition for treating cancer and preparation method thereof - Google Patents
Medical composition for treating cancer and preparation method thereof Download PDFInfo
- Publication number
- CN101991841A CN101991841A CN2009100908561A CN200910090856A CN101991841A CN 101991841 A CN101991841 A CN 101991841A CN 2009100908561 A CN2009100908561 A CN 2009100908561A CN 200910090856 A CN200910090856 A CN 200910090856A CN 101991841 A CN101991841 A CN 101991841A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- pharmaceutical composition
- cancer
- medical composition
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medical composition for treating cancer. The medical composition comprises black ants, lucid ganoderma, selenium and albumen powder. The medical composition consists of traditional Chinese medicine and a small quantity of trace elements; and proved by hundreds of cases, after the medical composition is taken, a membrane can be generated to wrap cancer in the organism to stop the nutrient source of the cancer, thus cancer cells cannot obtain nutrition and gradually wither and go to apoptosis, and the medical composition has no damage to normal cells. The medical composition can promote immune cells to reproduce and grow and improve the immunocompetence of the organism. The medical composition contains an antibiotic capable of resisting bacteria and various viruses, and at present, the antibiotic of the composition is not prepared in the world. The medical composition has the effects of resisting tumors, suppressing and killing tumors, reducing side effects of chemotherapy and pharmaceutical care, enhancing the immunity of the organism, increasing leucocytes, radically treating rheumatoid chronic diseases, and the like.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of cancer and preparation method thereof.
Background technology
Talk the cancer complexion changed, be present people's normality, but should change theory, regard it as a kind of chronic disease.Chinese's American world immunologist once said: malignant tumor can be divided two classes, one class is pathologic, one class is physiological, and this two class is divided two stages again from the age, after promptly 60 years old and before 60 years old, 60 years old is later on physiological, the people that this stage is dissected its corpse 80% has carcinoma, and it is big like Ovum Anas domestica that the corpse of dissecting more than 80 year old has, but do not have much miseries before death, so the physiological patient can take conservative treatment promptly to take medicine, annotate pin etc.Another kind of promptly pathologic, this class patient, the conventional therapy of China is promptly performed the operation chemotherapy, medication immediately after the operation at present.This has just destroyed the immune function of self greatly, alopecia, vomiting, loss of appetite, cancerous cell diffusion etc.Clinical data shows that the cancer patient one of China makes a definite diagnosis the middle and advanced stage of having arrived, so five-year survival rate only is 25%, and American-European developed country five-year survival rate accounts for 68%.
Summary of the invention
The object of the present invention is to provide a kind of pharmaceutical composition for the treatment of cancer;
Another object of the present invention is to provide this preparation of drug combination method.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Formica fusca 30-100 weight portion Ganoderma 7-22 weight portion selenium 2-7 weight portion egg albumen powder 5-15 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Formica fusca 70 weight portion Ganodermas 15 weight portion selenium 5 weight portion egg albumen powders 10 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Formica fusca 90 weight portion Ganodermas 8 weight portion selenium 6 weight portion egg albumen powders 6 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Formica fusca 40 weight portion Ganodermas 20 weight portion selenium 3 weight portion egg albumen powders 13 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Formica fusca 50 weight portion Ganodermas 10 weight portion selenium 4 weight portion egg albumen powders 8 weight portions.
Get above-mentioned raw materials,, be ground into powder with fire drying in 40 ℃, the capsule of packing into No. 0.5, promptly.
Pharmaceutical composition of the present invention adds pharmaceutically conventional adjuvant according to common process and makes capsule, granule, pill, tablet, powder, oral liquid, injection or the lyophilized injectable powder of clinical acceptance.
Pharmaceutical composition of the present invention " cancer enemy " is the international doctor of medicine that the U.S. authorizes, and through the utilization of clinical research for many years Chinese medicine, has developed a kind of medicine through the science compatibility, the jinx of carcinoma by name.The present invention is made up of Chinese medicine and a small amount of trace element, through hundreds of example checkings, after taking, can produce a kind of film, encases the interior carcinoma of body, blocks its nutrient source, and cancerous cell can not get nutrition like this, just wither gradually, apoptosis, to normal cell without any infringement.Pharmaceutical composition of the present invention can promote immunocyte breeding growth, improves the immunocompetence of body.Its inherent a kind of antibiotic, antibiotic, the anti-multiple virus of energy does not also have this antibiotic at present in the world.Pharmaceutical composition of the present invention has antitumor, but goes out tumor, reduces the side effect of chemotherapy, medication; And energy enhancing human body immunity power, increase curative effects such as leukocyte and radical cure rheumatism class persistent ailment.
Following experimental example and embodiment are used to further specify the present invention but are not limited to the present invention.
Experimental example
One, physical data
Medicine composite for curing 220 examples of the present invention, the patient all is the outpatient, wherein the oldest 70 years old, minimum 40 years old; The course of disease had 15 examples in the longest 20 years, and 30 examples were arranged in the shortest 10 years.The patient effective percentage 90% of above-mentioned achievement more than 60 years old, the effective percentage 80% of cure rate below 80%, 60 years old, cure rate 70%.
Two, diagnostic criteria
The Western medicine diagnose standard: (1) finds cancerous cell from tissue fluid, can conclude the carcinoma in each organ.
(2) cancerous cell is found in every vital organs of the human body QI and blood place that can flow to, and can make a definite diagnosis.
The tcm diagnosis standard: touched lump from epidermis, the matter soft edges is unclear, is mostly malignant tumor.
Three, Therapeutic Method:
1, medicine is formed: Formica fusca 70g, Ganoderma 15g, selenium 5g, egg albumen powder 10g;
2, preparation method:
Get above-mentioned raw materials,, be ground into powder with fire drying in 40 ℃, the capsule of packing into No. 0.5, promptly.
3, function and curing mainly:
Cure mainly: the carcinoma of the vital organs of the human body all can be treated effective percentage about 90%.
Usage and consumption: 3 times on the oral one, a 5g (10), boiled water takes after meal.
Specification: capsule 0.5g * 100.
Attention: 1, curative effect can take effect after slow general January and can stablize in 3 months, year is almost recovered half a year to one.
2, allergy sufferers can be obeyed desensitizer or drug withdrawal.
Four, therapeutic outcome:
Medicine composite for curing cancer of the present invention amounts to 220 examples, produce effects 207 examples wherein, effective 210 examples.See Table 1:
Table 1 pharmaceutical composition curative effect of the present invention tables of data
To sum up, medicine composite for curing cancer 220 examples of the present invention, wherein, produce effects 207 examples, effective 210 examples, invalid 10 examples.Obvious effective rate is 94%, and effective percentage is 96%, inefficiency 4%.
Five, model case
Case 1: Shao *, woman, 47, Zibo 501 workers of factory in late period when finding tumor of kidney, are spread, take excision, vomit seriously during the chemotherapy of operation back, back clothes capsule of the present invention, up to recovery from illness, left hospital in 3 months, on half a year the class, after 1 year the check, do not find cancerous cell, hair is also perfect harmless.
Case 2: still * *, the man, 70 years old, the peasant, king villages and small towns, Zhoucun District, Zibo City He Jia people from village, gastric cancer is taken pill of the present invention, and 5 months are complete, and the odd jobs on the agricultural now can both be done.
Case 3: the week * *, the man, 56 years old, Zichuan businessman, pancreas tumor is taken granule of the present invention, half a year, the check, the tumor body disappears, the jumping of patient's happiness at that time get up.
Case 4: Soviet Union * *, Zibo City's Zhangdian District is examined through Shandong, Shandong hospital and is tumor of kidney, spreads (middle and advanced stage) just excision rapidly to the edge, thereupon, and medication, chemotherapy.Vomit during medication, do not take even a drop of water.Take tablet of the present invention, 4 days, the unusual symptom of all of digestive system just must be to control.Up to leaving hospital, hair is the same with healthy people, and now rehabilitation has comprehensively normally been gone to work, and after 2 years, cancerous cell is not found in check.
Case 5: open * *, the man, 68 years old, cancer of pancreas was suffered from Zichuan, Zichuan District, tumor has Ovum Anas domestica big, and is painful unusual, because of no money hospitalization, after take capsule of the present invention, half a year, tumor also has almond big, now still takes up to disappearance continuing.
Case 6: still * *, colon cancer is suffered from by Zhoucun District, after the operation, takes oral liquid of the present invention, does not accept chemotherapy and medication, existing 8 years, follow up a case by regular visits to, healthy, no any discomfort.
Case 7: the week *, the woman, 53 years old, people from Zhou village of Zhoucun District, Zibo City suffered from hepatocarcinoma 3 years, can not perform the operation, and took capsule of the present invention in 2 years always, followed up a case by regular visits to, and now was in a good state of health.
Case 8: poplar * *, 53 years old, Accessories during Binzhou people from Zouping examined through Shandong, Shandong Province hospital and to be pulmonary carcinoma, can not perform the operation, find 07 year second half year, after take pill of the present invention so far always, follow up a case by regular visits to, now still be in a good state of health.
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1: capsule
Formica fusca 70kg Ganoderma 15kg selenium 5kg egg albumen powder 10kg;
Get above-mentioned raw materials,, be ground into powder with fire drying in 40 ℃, the capsule of packing into No. 0.5, promptly.3 times on the oral one, a 5g (10).
Embodiment 2: granule
Formica fusca 90kg Ganoderma 8kg selenium 6kg egg albumen powder 6kg;
Above-mentioned raw materials is made the granule of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 3: pill
Formica fusca 40kg Ganoderma 20kg selenium 3kg egg albumen powder 13kg;
Above-mentioned raw materials is made the pill of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 4: tablet
Formica fusca 50kg Ganoderma 10kg selenium 4kg egg albumen powder 8kg;
Above-mentioned raw materials is made the tablet of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 5: powder
Formica fusca 70kg Ganoderma 15kg selenium 5kg egg albumen powder 10kg;
Above-mentioned raw materials is made the powder of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 6: oral liquid
Formica fusca 90kg Ganoderma 8kg selenium 6kg egg albumen powder 6kg;
Above-mentioned raw materials is made the oral liquid of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 7: injection
Formica fusca 40kg Ganoderma 20kg selenium 3kg egg albumen powder 13kg;
Above-mentioned raw materials is made the injection of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 8: lyophilized injectable powder
Formica fusca 50kg Ganoderma 10kg selenium 4kg egg albumen powder 8kg;
Above-mentioned raw materials is made the lyophilized injectable powder of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Claims (10)
1. pharmaceutical composition for the treatment of cancer is characterized in that the crude drug of this pharmaceutical composition consists of:
Formica fusca 30-100 weight portion Ganoderma 7-22 weight portion selenium 2-7 weight portion egg albumen powder 5-15 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Formica fusca 70 weight portion Ganodermas 15 weight portion selenium 5 weight portion egg albumen powders 10 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Formica fusca 90 weight portion Ganodermas 8 weight portion selenium 6 weight portion egg albumen powders 6 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Formica fusca 40 weight portion Ganodermas 20 weight portion selenium 3 weight portion egg albumen powders 13 weight portions.
5. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Formica fusca 50 weight portion Ganodermas 10 weight portion selenium 4 weight portion egg albumen powders 8 weight portions.
6. as the arbitrary described pharmaceutical composition of claim 1-5, it is characterized in that the conventional adjuvant on this pharmaceutical composition adding pharmaceutics is made the dosage form of clinical acceptance.
7. pharmaceutical composition as claimed in claim 6 is characterized in that described dosage form is capsule, granule, pill, tablet, powder, oral liquid, injection or lyophilized injectable powder.
8. as the arbitrary described preparation of drug combination method of claim 1-7, it is characterized in that this method is:
Get above-mentioned raw materials,, be ground into powder with fire drying in 40 ℃, the capsule of packing into No. 0.5, promptly.
9. as the application of the arbitrary described pharmaceutical composition of claim 1-7 in the medicine of preparation treatment cancer.
10. application as claimed in claim 9 is characterized in that wherein said cancer is meant hepatocarcinoma, pulmonary carcinoma, gastric cancer, renal carcinoma, cancer of pancreas or intestinal cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100908561A CN101991841A (en) | 2009-08-12 | 2009-08-12 | Medical composition for treating cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100908561A CN101991841A (en) | 2009-08-12 | 2009-08-12 | Medical composition for treating cancer and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991841A true CN101991841A (en) | 2011-03-30 |
Family
ID=43782918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100908561A Pending CN101991841A (en) | 2009-08-12 | 2009-08-12 | Medical composition for treating cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991841A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103861079A (en) * | 2014-03-14 | 2014-06-18 | 杨峻峻 | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors |
-
2009
- 2009-08-12 CN CN2009100908561A patent/CN101991841A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 周岱翰: "《临床中医肿瘤学》", 30 April 2003, 人民卫生出版社 * |
| 林洪生 李道睿: "生存质量与中医肿瘤疗效评价", 《癌症进展杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103861079A (en) * | 2014-03-14 | 2014-06-18 | 杨峻峻 | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors |
| CN103861079B (en) * | 2014-03-14 | 2015-05-20 | 杨峻峻 | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101491663B (en) | Traditional Chinese medicine composition for treating various cancer | |
| CN103861079B (en) | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors | |
| CN108785616A (en) | It strengthens the body resistance to consolidate the constitution Nude mice | |
| CN101062146A (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN101708285A (en) | Chinese medicinal composition for treating cancers and preparation method thereof | |
| CN102755600B (en) | Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence, preparation method and uses | |
| CN103432265A (en) | Traditional Chinese medicinal composition preparation for treating fever in children and preparation method thereof | |
| CN101209263A (en) | Medicine for treating tumor | |
| CN102526640A (en) | Pantoprazole sodium medicine compound and preparation technology thereof | |
| CN102579999A (en) | Medicine for treating carcinous fever and preparation method thereof | |
| CN101991841A (en) | Medical composition for treating cancer and preparation method thereof | |
| CN104524163B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic bronchitis and merging pulmonary carcinoma | |
| CN101036732A (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
| CN102755515A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN104491268A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method thereof | |
| CN103169929A (en) | Medicament for treating primary bronchogenic carcinoma | |
| CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
| CN106619870A (en) | Composition for treating digestive system neoplasms, and preparation method of composition | |
| CN102430054B (en) | Applications of traditional Chinese medicinal compound preparation for removing toxicity, resisting cancer, activating blood and dissipating mass | |
| CN102406728B (en) | Medicinal composition for treating lymphaden inflammations | |
| CN102698043A (en) | Medicinal combination for treating thyroid gland | |
| CN100553670C (en) | A kind of pharmaceutical composition for the treatment of rheumatalgia | |
| CN106266307B (en) | Ant bear gall pill and its preparation method and application | |
| CN101007114B (en) | An adjuvant drug or health food for tumor patients and preparation thereof | |
| CN105288050A (en) | Medicine for treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110330 |